CDEK by Data4ThePeople

Sign in Sign up

← All organizations

TotipotentRX

For profit

Also known as: TotipotentRX Cell Therapy Pvt. Ltd. | TotipotentSC Scientific Product Pvt. Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 1, 2014

Acquired by Cesca Therapeutics, Inc. on Jul 16, 2013

Timeline

2010s

Jun 1, 2011
TotipotentRX— Founded
Jul 16, 2013
Cesca Therapeutics, Inc.— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

bone autograft

Phase 1 (1 own, 0 via acquisition)

platelet-rich plasma

Indications

Studied for

Ulcer

Recent trials (6)

NCT03026855Lead sponsorPhase 1Jun 1, 2014
NCT01536106Lead sponsorPhase 1/Phase 2Dec 31, 2013
NCT01536106Study chairPhase 1/Phase 2Dec 31, 2013
NCT01536106Study directorPhase 1/Phase 2Dec 31, 2013
NCT01536106OfficialPhase 1/Phase 2Dec 31, 2013
NCT01472289Lead sponsorPhase 1/Phase 2Feb 28, 2011

Details

Founded: Los Angeles, CA, US Jun 1, 2011
Last known activity: Jun 1, 2014